1 / 9Bajaj Finance | The company approved raising Rs 10,000 crore through various methods on Thursday. The lender approved raising a sum not exceeding Rs 8,800 crore via a QIP. Additionally, it has also approved raising a sum not exceeding Rs 1,200 crore through a preferential issue of up to 15.5 lakh warrants convertible into an equivalent number of equity shares to its promoter company Bajaj Finserv.
2 / 9PB Fintech | Japan's SoftBank is reportedly gearing up to sell shares worth up to $105 million (Rs 876 crore) in PB Fintech through a block deal. Sources privy to the developments told CNBC-TV18 that this share sale may be offered at a slight discount, ranging from 0-2% off the current market price, which stands at Rs 767 per share.
3 / 9Adani Wilmar | The FMCG company said it witnessed double-digit volume growth and an increase in its rural sales in the September quarter. Large opportunities in packaged staple foods and strong execution boosted the volume growth, the firm said. While the volume growth was strong during the period under review, the sales value has dropped compared to the same period last year, it said.
4 / 9Tata Motors | The company on October 5 said that its luxury arm Jaguar Land Rover's retail sales, including the Chery Jaguar Land Rover China JV, rose 21% year-on-year to 106,561 units for the second quarter ended September 30, 2023. The company had posted retail sales of 88,121 units in the same quarter previous fiscal.
5 / 9Godrej Consumer Products | FMCG major said that despite facing challenges like weak macroeconomic conditions and adverse weather in India, the organic business of the company delivered a steady performance with mid-single-digit volume growth in the second quarter ended September 2023.
6 / 9Sun Pharma | The drug major has entered into an agreement to acquire a minority stake in Ezerx Health Tech Private Ltd for Rs 28.69 crore. Under the terms of the agreement, Sun Pharma will acquire a 37.76 percent equity shareholding in EzeRx at a cost of Rs 28.69 crore, according to a stock exchange filing.
7 / 9Utkarsh SFB | Microfinance lender said that its gross loan portfolio registered a substantial year-on-year surge of 26.4 percent, reaching Rs 14,894 crore. Further, the bank's total deposits marked a notable 19 percent increase year-on-year, totalling Rs 13,965 crore.
8 / 9Lupin | The drug firm has secured tentative approval from the US FDA for its Abbreviated New Drug Application concerning tolvaptan tablets. These tablets are available in various strengths, including 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg, and are intended to serve as a generic equivalent to Jynarque tablets, a product by Otsuka Pharmaceutical Co Ltd.
9 / 9Tinplate Company of India | The company said the Office of the Deputy Commissioner of Commercial Taxes, Jamshedpur Circle, has imposed a penalty of Rs 39.9 crore on the company. This penalty is in connection with a prior demand order issued by the Deputy Commissioner of Commercial Taxes, Jamshedpur, relating to the fiscal year 2016-17.
